asthma
ASTHMA
Asthma is a chronic inflammatory disease of the airways in the lungs of children and adults.
The patient usually complains of shortness of breath, chest tightness and coughing with wheezing.
Goals of treatment are effective symptom control with minimal or no exacerbations, minimal or no nocturnal and daytime symptoms, no limitations on activities, minimal or no need for reliever treatment, and minimal adverse effects of medication.

Definition

  • Defined as a heterogeneous disease characterized by chronic airway inflammation that results in recurrent episodes of wheeze, shortness of breath (SOB), chest tightness &/or cough that vary over time & in intensity, with variable expiratory airflow limitation

Signs and Symptoms

  • Symptoms are usually associated with airflow obstruction; which is often reversible either spontaneously or with treatment
  • These symptoms tend to be intermittent, variable, worse at night or upon waking, & provoked by triggers, eg exercise, allergens, weather changes, viral infections

Risk Factors

  • Asthma phenotypes (clusters of asthma characteristics) differ in clinical manifestations, pathophysiology & demographic location of the patient
    • Allergic asthma: present in childhood, with a positive family history of asthma, & previous history of allergy such as eczema, food allergy, allergic rhinitis, etc
    • Non-allergic asthma: also called adult-onset; asthma presenting & diagnosed for the 1st time in adult years
    • Asthma with fixed airflow limitation: airway wall remodeling due to chronic airway inflammation causing irreversible airflow obstruction
    • Asthma with obesity: prevalence of symptomatic asthma is increased in those suffering from obesity
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.